Expression and Regulation of Nampt in Human Islets

Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester

(2014) M. Akturk et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Gene expression in cardiac tissues from infants with idiopathic conotruncal defects

(2011) Douglas C Bittel et al.   BMC Medical Genomics

Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice

(2011) Jun Yoshino et al.   Cell Metabolism

Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function

(2011) P. W. Caton et al.   DIABETOLOGIA

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

(2011) D. Friebe et al.   DIABETOLOGIA

Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats

(2009) Qin Sun et al.   ANNALS OF MEDICINE

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

(2009) A. Garten et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells

(2009) James E P Brown et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study

(2008) Ravi Retnakaran et al.   CLINICAL ENDOCRINOLOGY

Visfatin expression is not associated with adipose tissue abundance in the porcine model

(2008) Marie-France Palin et al.   DOMESTIC ANIMAL ENDOCRINOLOGY